Global Gabapentin Enacarbil Market Growth 2020-2025


Sep, 2020 | Report ID: 149561 | 163 | Pharmaceuticals and Healthcare

According to this study, over the next five years the Gabapentin Enacarbil market will register a XX%% CAGR in terms of revenue, the global market size will reach $ XX million by 2025, from $ XX million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Gabapentin Enacarbil business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin Enacarbil market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Gabapentin Enacarbil, covering the supply chain analysis, impact assessment to the Gabapentin Enacarbil market size growth rate in several scenarios, and the measures to be undertaken by Gabapentin Enacarbil companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Capsule

Tablet

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Post-Herpetic Neuralgia (PHN)

Restless Legs Syndrome (RLS)

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Arbor Pharma

Apotex

Astellas

Glenmark Pharma

Pfizer

GlaxoSmithKline

Mylan

Depomed

Novartis

Teva

Alkem

Jiangsu Hengrui

Jiangsu Enhua

Sun Pharmaceutical

Amneal

Intas

Marksans Pharma

Aurobindo Pharma

Sailike Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Gabapentin Enacarbil consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Gabapentin Enacarbil market by identifying its various subsegments.

Focuses on the key global Gabapentin Enacarbil manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Gabapentin Enacarbil with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Gabapentin Enacarbil submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gabapentin Enacarbil Consumption 2015-2025

2.1.2 Gabapentin Enacarbil Consumption CAGR by Region

2.2 Gabapentin Enacarbil Segment by Type

2.2.1 Capsule

2.2.2 Tablet

2.3 Gabapentin Enacarbil Consumption by Type

2.3.1 Global Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)

2.3.2 Global Gabapentin Enacarbil Revenue and Market Share by Type (2015-2020)

2.3.3 Global Gabapentin Enacarbil Sale Price by Type (2015-2020)

2.4 Gabapentin Enacarbil Segment by Application

2.4.1 Post-Herpetic Neuralgia (PHN)

2.4.2 Restless Legs Syndrome (RLS)

2.4.3 Others

2.5 Gabapentin Enacarbil Consumption by Application

2.5.1 Global Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)

2.5.2 Global Gabapentin Enacarbil Value and Market Share by Type (2015-2020)

2.5.3 Global Gabapentin Enacarbil Sale Price by Type (2015-2020)

3 Global Gabapentin Enacarbil by Company

3.1 Global Gabapentin Enacarbil Sales Market Share by Company

3.1.1 Global Gabapentin Enacarbil Sales by Company (2018-2020)

3.1.2 Global Gabapentin Enacarbil Sales Market Share by Company (2018-2020)

3.2 Global Gabapentin Enacarbil Revenue Market Share by Company

3.2.1 Global Gabapentin Enacarbil Revenue by Company (2018-2020)

3.2.2 Global Gabapentin Enacarbil Revenue Market Share by Company (2018-2020)

3.3 Global Gabapentin Enacarbil Sale Price by Company

3.4 Global Gabapentin Enacarbil Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Gabapentin Enacarbil Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Gabapentin Enacarbil Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Gabapentin Enacarbil by Regions

4.1 Gabapentin Enacarbil by Regions

4.2 Americas Gabapentin Enacarbil Consumption Growth

4.3 APAC Gabapentin Enacarbil Consumption Growth

4.4 Europe Gabapentin Enacarbil Consumption Growth

4.5 Middle East & Africa Gabapentin Enacarbil Consumption Growth

5 Americas

5.1 Americas Gabapentin Enacarbil Consumption by Countries

5.1.1 Americas Gabapentin Enacarbil Consumption by Countries (2015-2020)

5.1.2 Americas Gabapentin Enacarbil Value by Countries (2015-2020)

5.2 Americas Gabapentin Enacarbil Consumption by Type

5.3 Americas Gabapentin Enacarbil Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Gabapentin Enacarbil Consumption by Regions

6.1.1 APAC Gabapentin Enacarbil Consumption by Regions (2015-2020)

6.1.2 APAC Gabapentin Enacarbil Value by Regions (2015-2020)

6.2 APAC Gabapentin Enacarbil Consumption by Type

6.3 APAC Gabapentin Enacarbil Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Gabapentin Enacarbil by Countries

7.1.1 Europe Gabapentin Enacarbil Consumption by Countries (2015-2020)

7.1.2 Europe Gabapentin Enacarbil Value by Countries (2015-2020)

7.2 Europe Gabapentin Enacarbil Consumption by Type

7.3 Europe Gabapentin Enacarbil Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Gabapentin Enacarbil by Countries

8.1.1 Middle East & Africa Gabapentin Enacarbil Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Gabapentin Enacarbil Value by Countries (2015-2020)

8.2 Middle East & Africa Gabapentin Enacarbil Consumption by Type

8.3 Middle East & Africa Gabapentin Enacarbil Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Gabapentin Enacarbil Distributors

10.3 Gabapentin Enacarbil Customer

11 Global Gabapentin Enacarbil Market Forecast

11.1 Global Gabapentin Enacarbil Consumption Forecast (2021-2025)

11.2 Global Gabapentin Enacarbil Forecast by Regions

11.2.1 Global Gabapentin Enacarbil Forecast by Regions (2021-2025)

11.2.2 Global Gabapentin Enacarbil Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Gabapentin Enacarbil Forecast by Type

11.8 Global Gabapentin Enacarbil Forecast by Application

12 Key Players Analysis

12.1 Arbor Pharma

12.1.1 Company Information

12.1.2 Gabapentin Enacarbil Product Offered

12.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Arbor Pharma Latest Developments

12.2 Apotex

12.2.1 Company Information

12.2.2 Gabapentin Enacarbil Product Offered

12.2.3 Apotex Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Apotex Latest Developments

12.3 Astellas

12.3.1 Company Information

12.3.2 Gabapentin Enacarbil Product Offered

12.3.3 Astellas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Astellas Latest Developments

12.4 Glenmark Pharma

12.4.1 Company Information

12.4.2 Gabapentin Enacarbil Product Offered

12.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Glenmark Pharma Latest Developments

12.5 Pfizer

12.5.1 Company Information

12.5.2 Gabapentin Enacarbil Product Offered

12.5.3 Pfizer Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Pfizer Latest Developments

12.6 GlaxoSmithKline

12.6.1 Company Information

12.6.2 Gabapentin Enacarbil Product Offered

12.6.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 GlaxoSmithKline Latest Developments

12.7 Mylan

12.7.1 Company Information

12.7.2 Gabapentin Enacarbil Product Offered

12.7.3 Mylan Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Mylan Latest Developments

12.8 Depomed

12.8.1 Company Information

12.8.2 Gabapentin Enacarbil Product Offered

12.8.3 Depomed Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Depomed Latest Developments

12.9 Novartis

12.9.1 Company Information

12.9.2 Gabapentin Enacarbil Product Offered

12.9.3 Novartis Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Novartis Latest Developments

12.10 Teva

12.10.1 Company Information

12.10.2 Gabapentin Enacarbil Product Offered

12.10.3 Teva Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Teva Latest Developments

12.11 Alkem

12.11.1 Company Information

12.11.2 Gabapentin Enacarbil Product Offered

12.11.3 Alkem Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 Alkem Latest Developments

12.12 Jiangsu Hengrui

12.12.1 Company Information

12.12.2 Gabapentin Enacarbil Product Offered

12.12.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 Jiangsu Hengrui Latest Developments

12.13 Jiangsu Enhua

12.13.1 Company Information

12.13.2 Gabapentin Enacarbil Product Offered

12.13.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Jiangsu Enhua Latest Developments

12.14 Sun Pharmaceutical

12.14.1 Company Information

12.14.2 Gabapentin Enacarbil Product Offered

12.14.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.14.4 Main Business Overview

12.14.5 Sun Pharmaceutical Latest Developments

12.15 Amneal

12.15.1 Company Information

12.15.2 Gabapentin Enacarbil Product Offered

12.15.3 Amneal Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.15.4 Main Business Overview

12.15.5 Amneal Latest Developments

12.16 Intas

12.16.1 Company Information

12.16.2 Gabapentin Enacarbil Product Offered

12.16.3 Intas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.16.4 Main Business Overview

12.16.5 Intas Latest Developments

12.17 Marksans Pharma

12.17.1 Company Information

12.17.2 Gabapentin Enacarbil Product Offered

12.17.3 Marksans Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.17.4 Main Business Overview

12.17.5 Marksans Pharma Latest Developments

12.18 Aurobindo Pharma

12.18.1 Company Information

12.18.2 Gabapentin Enacarbil Product Offered

12.18.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.18.4 Main Business Overview

12.18.5 Aurobindo Pharma Latest Developments

12.19 Sailike Pharma

12.19.1 Company Information

12.19.2 Gabapentin Enacarbil Product Offered

12.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2020)

12.19.4 Main Business Overview

12.19.5 Sailike Pharma Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Gabapentin Enacarbil Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Capsule

Table 5. Major Players of Tablet

Table 6. Global Consumption Sales by Type (2015-2020)

Table 7. Global Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)

Table 8. Global Gabapentin Enacarbil Revenue by Type (2015-2020) ($ million)

Table 9. Global Gabapentin Enacarbil Value Market Share by Type (2015-2020) ($ Millions)

Table 10. Global Gabapentin Enacarbil Sale Price by Type (2015-2020)

Table 11. Global Consumption Sales by Application (2015-2020)

Table 12. Global Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)

Table 13. Global Gabapentin Enacarbil Value by Application (2015-2020)

Table 14. Global Gabapentin Enacarbil Value Market Share by Application (2015-2020)

Table 15. Global Gabapentin Enacarbil Sale Price by Application (2015-2020)

Table 16. Global Gabapentin Enacarbil Sales by Company (2017-2019) (K Units)

Table 17. Global Gabapentin Enacarbil Sales Market Share by Company (2017-2019)

Table 18. Global Gabapentin Enacarbil Revenue by Company (2017-2019) ($ Millions)

Table 19. Global Gabapentin Enacarbil Revenue Market Share by Company (2017-2019)

Table 20. Global Gabapentin Enacarbil Sale Price by Company (2017-2019)

Table 21. Global Gabapentin Enacarbil Manufacturing Base Distribution and Sales Area by Manufacturers

Table 22. Players Gabapentin Enacarbil Products Offered

Table 23. Gabapentin Enacarbil Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 24. Global Gabapentin Enacarbil Consumption by Regions 2015-2020 (K Units)

Table 25. Global Gabapentin Enacarbil Consumption Market Share by Regions 2015-2020

Table 26. Global Gabapentin Enacarbil Value by Regions 2015-2020 ($ Millions)

Table 27. Global Gabapentin Enacarbil Value Market Share by Regions 2015-2020

Table 28. Americas Gabapentin Enacarbil Consumption by Countries (2015-2020) (K Units)

Table 29. Americas Gabapentin Enacarbil Consumption Market Share by Countries (2015-2020)

Table 30. Americas Gabapentin Enacarbil Value by Countries (2015-2020) ($ Millions)

Table 31. Americas Gabapentin Enacarbil Value Market Share by Countries (2015-2020)

Table 32. Americas Gabapentin Enacarbil Consumption by Type (2015-2020) (K Units)

Table 33. Americas Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)

Table 34. Americas Gabapentin Enacarbil Consumption by Application (2015-2020) (K Units)

Table 35. Americas Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)

Table 36. APAC Gabapentin Enacarbil Consumption by Countries (2015-2020) (K Units)

Table 37. APAC Gabapentin Enacarbil Consumption Market Share by Countries (2015-2020)

Table 38. APAC Gabapentin Enacarbil Value by Regions (2015-2020) ($ Millions)

Table 39. APAC Gabapentin Enacarbil Value Market Share by Regions (2015-2020)

Table 40. APAC Gabapentin Enacarbil Consumption by Type (2015-2020) (K Units)

Table 41. APAC Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)

Table 42. APAC Gabapentin Enacarbil Consumption by Application (2015-2020) (K Units)

Table 43. APAC Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)

Table 44. Europe Gabapentin Enacarbil Consumption by Countries (2015-2020) (K Units)

Table 45. Europe Gabapentin Enacarbil Consumption Market Share by Countries (2015-2020)

Table 46. Europe Gabapentin Enacarbil Value by Countries (2015-2020) ($ Millions)

Table 47. Europe Gabapentin Enacarbil Value Market Share by Countries (2015-2020)

Table 48. Europe Gabapentin Enacarbil Consumption by Type (2015-2020) (K Units)

Table 49. Europe Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)

Table 50. Europe Gabapentin Enacarbil Consumption by Application (2015-2020) (K Units)

Table 51. Europe Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)

Table 52. Middle East & Africa Gabapentin Enacarbil Consumption by Countries (2015-2020) (K Units)

Table 53. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Countries (2015-2020)

Table 54. Middle East & Africa Gabapentin Enacarbil Value by Countries (2015-2020) ($ Millions)

Table 55. Middle East & Africa Gabapentin Enacarbil Value Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Gabapentin Enacarbil Consumption by Type (2015-2020) (K Units)

Table 57. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)

Table 58. Middle East & Africa Gabapentin Enacarbil Consumption by Application (2015-2020) (K Units)

Table 59. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)

Table 60. Gabapentin Enacarbil Distributors List

Table 61. Gabapentin Enacarbil Customer List

Table 62. Global Gabapentin Enacarbil Consumption Forecast by Countries (2021-2025) (K Units)

Table 63. Global Gabapentin Enacarbil Consumption Market Forecast by Regions

Table 64. Global Gabapentin Enacarbil Value Forecast by Countries (2021-2025) ($ Millions)

Table 65. Global Gabapentin Enacarbil Value Market Share Forecast by Regions

Table 66. Global Gabapentin Enacarbil Consumption Forecast by Type (2021-2025) (K Units)

Table 67. Global Gabapentin Enacarbil Consumption Market Share Forecast by Type (2021-2025)

Table 68. Global Gabapentin Enacarbil Value Forecast by Type (2021-2025) ($ Millions)

Table 69. Global Gabapentin Enacarbil Value Market Share Forecast by Type (2021-2025)

Table 70. Global Gabapentin Enacarbil Consumption Forecast by Application (2021-2025) (K Units)

Table 71. Global Gabapentin Enacarbil Consumption Market Share Forecast by Application (2021-2025)

Table 72. Global Gabapentin Enacarbil Value Forecast by Application (2021-2025) ($ Millions)

Table 73. Global Gabapentin Enacarbil Value Market Share Forecast by Application (2021-2025)

Table 74. Arbor Pharma Product Offered

Table 75. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 76. Arbor Pharma Main Business

Table 77. Arbor Pharma Latest Developments

Table 78. Arbor Pharma Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 79. Apotex Product Offered

Table 80. Apotex Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 81. Apotex Main Business

Table 82. Apotex Latest Developments

Table 83. Apotex Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 84. Astellas Product Offered

Table 85. Astellas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 86. Astellas Main Business

Table 87. Astellas Latest Developments

Table 88. Astellas Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 89. Glenmark Pharma Product Offered

Table 90. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 91. Glenmark Pharma Main Business

Table 92. Glenmark Pharma Latest Developments

Table 93. Glenmark Pharma Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 94. Pfizer Product Offered

Table 95. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 96. Pfizer Main Business

Table 97. Pfizer Latest Developments

Table 98. Pfizer Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 99. GlaxoSmithKline Product Offered

Table 100. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 101. GlaxoSmithKline Main Business

Table 102. GlaxoSmithKline Latest Developments

Table 103. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 104. Mylan Product Offered

Table 105. Mylan Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 106. Mylan Main Business

Table 107. Mylan Latest Developments

Table 108. Mylan Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 109. Depomed Product Offered

Table 110. Depomed Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 111. Depomed Main Business

Table 112. Depomed Latest Developments

Table 113. Depomed Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 114. Novartis Product Offered

Table 115. Novartis Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 116. Novartis Main Business

Table 117. Novartis Latest Developments

Table 118. Novartis Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 119. Teva Product Offered

Table 120. Teva Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 121. Teva Main Business

Table 122. Teva Latest Developments

Table 123. Teva Basic Information, Company Total Revenue (in $ million), Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors

Table 124. Alkem Product Offered

Table 125. Alkem Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 126. Alkem Main Business

Table 127. Alkem Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 128. Alkem Latest Developments

Table 129. Jiangsu Hengrui Product Offered

Table 130. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 131. Jiangsu Hengrui Main Business

Table 132. Jiangsu Hengrui Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 133. Jiangsu Hengrui Latest Developments

Table 134. Jiangsu Enhua Product Offered

Table 135. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 136. Jiangsu Enhua Main Business

Table 137. Jiangsu Enhua Latest Developments

Table 138. Jiangsu Enhua Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 139. Sun Pharmaceutical Product Offered

Table 140. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 141. Sun Pharmaceutical Main Business

Table 142. Sun Pharmaceutical Latest Developments

Table 143. Sun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 144. Amneal Product Offered

Table 145. Amneal Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 146. Amneal Main Business

Table 147. Amneal Latest Developments

Table 148. Amneal Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 149. Intas Product Offered

Table 150. Intas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 151. Intas Main Business

Table 152. Intas Latest Developments

Table 153. Intas Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 154. Marksans Pharma Product Offered

Table 155. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 156. Marksans Pharma Main Business

Table 157. Marksans Pharma Latest Developments

Table 158. Marksans Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 159. Aurobindo Pharma Product Offered

Table 160. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 161. Aurobindo Pharma Main Business

Table 162. Aurobindo Pharma Latest Developments

Table 163. Aurobindo Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 164. Sailike Pharma Product Offered

Table 165. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 166. Sailike Pharma Main Business

Table 167. Sailike Pharma Latest Developments

Table 168. Sailike Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Gabapentin Enacarbil

Figure 2. Gabapentin Enacarbil Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Gabapentin Enacarbil Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Gabapentin Enacarbil Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Capsule

Figure 7. Product Picture of Tablet

Figure 8. Global Gabapentin Enacarbil Consumption Market Share by Type (2015-2020)

Figure 9. Global Gabapentin Enacarbil Value Market Share by Type (2015-2020)

Figure 10. Gabapentin Enacarbil Consumed in Post-Herpetic Neuralgia (PHN)

Figure 11. Global Gabapentin Enacarbil Market: Post-Herpetic Neuralgia (PHN) (2015-2020) (K Units)

Figure 12. Global Gabapentin Enacarbil Market: Post-Herpetic Neuralgia (PHN) (2015-2020) ($ Millions)

Figure 13. Gabapentin Enacarbil Consumed in Restless Legs Syndrome (RLS)

Figure 14. Global Gabapentin Enacarbil Market: Restless Legs Syndrome (RLS) (2015-2020) (K Units)

Figure 15. Global Gabapentin Enacarbil Market: Restless Legs Syndrome (RLS) (2015-2020) ($ Millions)

Figure 16. Gabapentin Enacarbil Consumed in Others

Figure 17. Global Gabapentin Enacarbil Market: Others (2015-2020) (K Units)

Figure 18. Global Gabapentin Enacarbil Market: Others (2015-2020) ($ Millions)

Figure 19. Global Gabapentin Enacarbil Consumption Market Share by Application (2015-2020)

Figure 20. Global Gabapentin Enacarbil Value Market Share by Application (2015-2020)

Figure 21. Global Gabapentin Enacarbil Sales Market Share by Company in 2017

Figure 22. Global Gabapentin Enacarbil Sales Market Share by Company in 2019

Figure 23. Global Gabapentin Enacarbil Revenue Market Share by Company in 2017

Figure 24. Global Gabapentin Enacarbil Revenue Market Share by Company in 2019

Figure 25. Global Gabapentin Enacarbil Sale Price by Company in 2019

Figure 26. Global Gabapentin Enacarbil Consumption Market Share by Regions 2015-2020

Figure 27. Global Gabapentin Enacarbil Value Market Share by Regions 2015-2020

Figure 28. Americas Gabapentin Enacarbil Consumption 2015-2020 (K Units)

Figure 29. Americas Gabapentin Enacarbil Value 2015-2020 ($ Millions)

Figure 30. APAC Gabapentin Enacarbil Consumption 2015-2020 (K Units)

Figure 31. APAC Gabapentin Enacarbil Value 2015-2020 ($ Millions)

Figure 32. Europe Gabapentin Enacarbil Consumption 2015-2020 (K Units)

Figure 33. Europe Gabapentin Enacarbil Value 2015-2020 ($ Millions)

Figure 34. Middle East & Africa Gabapentin Enacarbil Consumption 2015-2020 (K Units)

Figure 35. Middle East & Africa Gabapentin Enacarbil Value 2015-2020 ($ Millions)

Figure 36. Americas Gabapentin Enacarbil Consumption Market Share by Countries in 2019

Figure 37. Americas Gabapentin Enacarbil Value Market Share by Countries in 2019

Figure 38. Americas Gabapentin Enacarbil Consumption Market Share by Type in 2019

Figure 39. Americas Gabapentin Enacarbil Consumption Market Share by Application in 2019

Figure 40. United States Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 41. United States Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 42. Canada Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 43. Canada Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 44. Mexico Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 45. Mexico Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 46. APAC Gabapentin Enacarbil Consumption Market Share by Countries in 2019

Figure 47. APAC Gabapentin Enacarbil Value Market Share by Regions in 2019

Figure 48. APAC Gabapentin Enacarbil Consumption Market Share by Type in 2019

Figure 49. APAC Gabapentin Enacarbil Consumption Market Share by Application in 2019

Figure 50. China Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 51. China Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 52. Japan Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 53. Japan Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 54. Korea Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 55. Korea Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 56. Southeast Asia Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 57. Southeast Asia Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 58. India Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 59. India Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 60. Australia Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 61. Australia Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 62. Europe Gabapentin Enacarbil Consumption Market Share by Countries in 2019

Figure 63. Europe Gabapentin Enacarbil Value Market Share by Countries in 2019

Figure 64. Europe Gabapentin Enacarbil Consumption Market Share by Type in 2019

Figure 65. Europe Gabapentin Enacarbil Consumption Market Share by Application in 2019

Figure 66. Germany Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 67. Germany Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 68. France Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 69. France Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 70. UK Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 71. UK Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 72. Italy Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 73. Italy Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 74. Russia Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 75. Russia Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 76. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Countries in 2019

Figure 77. Middle East & Africa Gabapentin Enacarbil Value Market Share by Countries in 2019

Figure 78. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Type in 2019

Figure 79. Middle East & Africa Gabapentin Enacarbil Consumption Market Share by Application in 2019

Figure 80. Egypt Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 81. Egypt Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 82. South Africa Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 83. South Africa Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 84. Israel Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 85. Israel Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 86. Turkey Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 87. Turkey Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 88. GCC Countries Gabapentin Enacarbil Consumption Growth 2015-2020 (K Units)

Figure 89. GCC Countries Gabapentin Enacarbil Value Growth 2015-2020 ($ Millions)

Figure 90. Global Gabapentin Enacarbil Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 91. Global Gabapentin Enacarbil Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 92. Americas Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 93. Americas Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 94. APAC Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 95. APAC Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 96. Europe Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 97. Europe Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 98. Middle East & Africa Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 99. Middle East & Africa Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 100. United States Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 101. United States Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 102. Canada Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 103. Canada Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 104. Mexico Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 105. Mexico Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 106. Brazil Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 107. Brazil Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 108. China Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 109. China Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 110. Japan Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 111. Japan Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 112. Korea Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 113. Korea Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 114. Southeast Asia Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 115. Southeast Asia Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 116. India Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 117. India Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 118. Australia Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 119. Australia Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 120. Germany Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 121. Germany Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 122. France Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 123. France Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 124. UK Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 125. UK Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 126. Italy Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 127. Italy Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 128. Russia Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 129. Russia Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 130. Spain Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 131. Spain Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 132. Egypt Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 133. Egypt Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 134. South Africa Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 135. South Africa Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 136. Israel Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 137. Israel Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 138. Turkey Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 139. Turkey Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 140. GCC Countries Gabapentin Enacarbil Consumption 2021-2025 (K Units)

Figure 141. GCC Countries Gabapentin Enacarbil Value 2021-2025 ($ Millions)

Figure 142. Arbor Pharma Gabapentin Enacarbil Market Share (2018-2020)

Figure 143. Apotex Gabapentin Enacarbil Market Share (2018-2020)

Figure 144. Astellas Gabapentin Enacarbil Market Share (2018-2020)

Figure 145. Glenmark Pharma Gabapentin Enacarbil Market Share (2018-2020)

Figure 146. Pfizer Gabapentin Enacarbil Market Share (2018-2020)

Figure 147. GlaxoSmithKline Gabapentin Enacarbil Market Share (2018-2020)

Figure 148. Mylan Gabapentin Enacarbil Market Share (2018-2020)

Figure 149. Depomed Gabapentin Enacarbil Market Share (2018-2020)

Figure 150. Novartis Gabapentin Enacarbil Market Share (2018-2020)

Figure 151. Teva Gabapentin Enacarbil Market Share (2018-2020)

Figure 152. Alkem Gabapentin Enacarbil Market Share (2018-2020)

Figure 153. Jiangsu Hengrui Gabapentin Enacarbil Market Share (2018-2020)

Figure 154. Jiangsu Enhua Gabapentin Enacarbil Market Share (2018-2020)

Figure 155. Sun Pharmaceutical Gabapentin Enacarbil Market Share (2018-2020)

Figure 156. Amneal Gabapentin Enacarbil Market Share (2018-2020)

Figure 157. Intas Gabapentin Enacarbil Market Share (2018-2020)

Figure 158. Marksans Pharma Gabapentin Enacarbil Market Share (2018-2020)

Figure 159. Aurobindo Pharma Gabapentin Enacarbil Market Share (2018-2020)

Figure 160. Sailike Pharma Gabapentin Enacarbil Market Share (2018-2020)

Sample Request is not available